All News

There’s Always Hope After an ‘Incurable’ Cancer Diagnosis, Thanks to Devoted Researchers

November 18th 2021

A cancer survivor explains how the new treatments coming out for all types of cancer give her hope. “If we are diagnosed today, a cure or remission may come out next week or next month, or next year to give us additional time to live,” she writes.

In Sickness and in Health: When Both Partners Have Cancer

November 18th 2021

On this episode of the “Cancer Horizons” podcast, actress and comedian Jessica St. Clair and writer Dan O’Brien share their cancer stories and how they channeled their emotions through creativity.

Phase 2 Trial Initiated for Second Line Treatment of AML and MDS

November 18th 2021

A phase 2 trial of aspacytarabine (BST-236) was initiated in patients with AML and MDS.

Adding Imbruvica to CAR-T Cell Therapy May Improve CLL Outcomes

November 17th 2021

Imbruvica plus Breyanzi, a CAR-T cell therapy, improved outcomes in patients with relapsed/refractory chronic lymphocytic leukemia, according to recent research.

Unpacking the Current Treatment Options for Metastatic Breast Cancer

November 17th 2021

An expert explains what treatment strategies are available for patients with metastatic breast cancer, how far research has come and why patients shouldn’t lose hope.

‘So Much for my Big Plan’ to Bid Farewell to Cancer: A Reflection on Tumor Markers During Survivorship

November 17th 2021

A cancer survivor describes the emotional rollercoaster of learning her tumor marker levels have risen. "I had decided that this would be the year I would bid farewell to my cancer journey. So much for my big plan," she writes.

Certain Cancer Immunotherapies May Lead to ‘Potential Small Risk’ for Myocarditis

November 17th 2021

Although the risk for myocarditis related to immune checkpoint inhibitors is an estimated 1%, findings from a recent study highlight the need for improved ways to screen and treat for this potential side effect.

A ‘Miraculous Class of Drugs’ to Increase Accessibility in Lung Cancer

November 17th 2021

Recent results may lead to more checkpoint inhibitor options and lower treatment prices, giving accessibility to more patients with lung cancer worldwide.

Imfinzi-Chemo Combo Improves Survival for Mesothelioma

November 16th 2021

Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.

Younger Patients with Metastatic Colorectal Cancer May Not Be Living Significantly Longer Than Older Patients

November 16th 2021

The incidence of young-onset colorectal cancer has been increasing in the past years, and despite being more physically active and receiving more intense treatments, younger patients are not living longer with the disease than older patients.

Patient With Cancer Asks, ‘To Port or Not to Port?’

November 16th 2021

A woman with ovarian cancer explains why she was reluctant to get a port put in and why she ultimately went forward with it. “Somehow, I felt that if I got the port, I was giving in to the cancer,” she writes.

How to Prepare for Breast Cancer Surgery: Know What Questions to Ask

November 16th 2021

A breast surgeon discusses what patients and their caregivers should know before breast cancer surgery.

Several Factors May Impact a Waldenstrom’s Macroglobulinemia Treatment Decision

November 16th 2021

Without a huge difference in efficacy between many of the available treatments for Waldenstrom’s macroglobulinemia, one expert says patients and their clinicians should look to other factors when deciding which regimen is best.

CAR-T Cell Therapy Trial Currently Enrolling Patients With CLL and SLL

November 16th 2021

The TRANSCEND CLL 004 trial is currently enrolling patients to determine the efficacy of a CAR-T cell therapy.

Men With Prostate Cancer After Surgery May Benefit From Shorter Duration of Radiation Therapy

November 15th 2021

Hypofractionated radiation for nearly five weeks in men with prostate cancer after surgery may have similar results without added side effects compared with radiation therapy for a standard duration of seven weeks.

The Complexity of Decision-Making for Early-Stage Breast Cancer Treatment

November 15th 2021

Navigating discussions around treatments for early-stage breast cancer may be difficult, but feeling comfortable with one’s cancer team and knowing about all the available options may help.

I Had No Prostate Cancer Symptoms, or so I Thought

November 15th 2021

A man reflects on slight symptoms he was not concerned about leading up to his prostate cancer diagnosis.

9/11 Firefighters and Unending Tragedy: 'Together as One Neighborhood'

November 15th 2021

Twenty years after 9/11, a retired firefighter reflects on the weeks following the attacks, as well as his own diagnosis of lung cancer six years later, in a newly published book.

Facing Disparities in Lung Cancer Mortality Rates

November 15th 2021

Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations.

How One Lung Cancer Survivor Can Inspire Another

November 14th 2021

"Having been newly diagnosed myself, I saw how amazingly well she was doing and had been a survivor for about three years already," a lung cancer survivor writes about a connection she made with another survivor.

Cancer Is Not My Sister, and My Sister Is Not Her Cancer

November 14th 2021

A woman describes the grueling experience of watching cancer attack her sister's body and wishing she could stop it.

‘A Rock and Gem’ of the Cancer Center

November 14th 2021

One patient details how her oncology nurse was the caring energy she needed when undergoing treatment for cancer.

First Patient Receives Novel Immunotherapy in Bladder Cancer Sub-Study

November 13th 2021

The first patient with bladder cancer was dosed in a phase 1/2 trial examining responses to an investigational immunotherapy.

Cancer Survivors Anonymous: Cancer Is Always at Your Doorstep, Much Like Alcoholism

November 13th 2021

A pancreatic cancer survivor makes a comparison between alcoholism and being a cancer survivor.

FDA Approves Besremi for Polycythemia Vera

November 13th 2021

The Food and Drug Administration granted approval to Besremi for the treatment of adults with polycythemia vera.

Hope Shared for Patients With Cancer Is Hope Multiplied

November 13th 2021

A patient with lung cancer explains how Terri Conneran, a patient advocate, helped her understand her disease and fight for proper care in a country with less options.

Guiding the Way for Patients With Lung Cancer: 'He Is my Hero'

November 12th 2021

A lung cancer survivor shares a heartfelt tribute to Dr. Abraham Chachoua, who changed his life.

The First of Many Advancements to Come for a Lung Cancer Mutation

November 12th 2021

Two new FDA approvals for patients with lung cancer and EGFR exon 20 insertion mutations have given the subset its first targeted therapies.

While I’m Busy Living With Metastatic Cancer, My Body Is Still Aging

November 12th 2021

A woman who has been living with metastatic breast cancer for seven years reflects on the strangeness of her body aging. “It’s the one thing I never imagined would happen after being diagnosed with and while living with a terminal illness – I’m actually getting old,” she writes.

Former South African President Frederik Willem de Klerk Dies From Cancer, Acid in Palm Oil Linked to Cancer Spread and More

November 12th 2021

From the death of Frederik Willem de Klerk to study results showing palm oil contains an acid that may cause cancer spread, here’s what’s happening in the cancer landscape this week.